MAPT and Alzheimer disease: Variant 4 (containing Phospho-Plus mutations in the R1-R2 region) showed lower seeded tau levels in the detergent-insoluble fraction compared to seeded P301L tau when seeded with AD Patient B (Fig. 1h; p < 0.01).